Zoetis Inc.

Pharmaceuticals
United States
Executive 1Mr. Frank A. D'Amelio, Chairman; | Chairman;
Executive 2Ms. Kristin C. Peck, Group President; Executive Vice President | Chief Operating Officer; Executive Board Member
Earnings Per Share Growth (%)14.85%
Cost of Goods Sold (US$ Millions)$1,717
Current Liabilities (US$ Millions)$1,086
Total Assets (US$ Millions)$3,465
Long Term Debt (Millions)$3,643
Return on Equity62.02%
Revenue (US$ Millions)$4,785
Total Company Assets$6,607
Revenue Growth (%)4.91%
Net Income (US$ Millions)$583
Earnings Per Share (US$)$1.16
Total Equity (US$ Millions)$1,311
Profit Margin (%)12.18%
Debt To Equity Ratio (%)2.78%
Inventories (Millions)$1,289